Related Experiment Video
Updated: May 21, 2026
12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
[Standardized nutritional intervention in hypoglycemic inpatients].
Silmara Rodrigues Machado1, Ana Lúcia Chalhoub Chediác Rodrigues, Sandra Cristine da Silva
1Unidade de Terapia Intensiva da Sociedade Beneficente de Senhoras do Hospital Sírio Libanês (SBS-HSL), São Paulo, Brasil. silmara.machado@hsl.org.br
Revista Gaucha De Enfermagem
|June 29, 2012
Summary
Rapid absorption carbohydrates (RAC) effectively treat hypoglycemia in conscious hospital patients on oral diets. This non-invasive nutritional intervention quickly restores capillary glucose levels, demonstrating high applicability and effectiveness in a general hospital setting.
Area of Science:
- Clinical Nutrition
- Endocrinology
- Internal Medicine
Background:
- Hypoglycemia is a common concern in hospitalized patients.
- Maintaining adequate glucose levels is crucial for patient recovery.
- Conscious patients on oral diets require accessible and effective glucose-raising interventions.
Purpose of the Study:
- To evaluate the effectiveness of rapid absorption carbohydrates (RAC) for treating hypoglycemia.
- To assess the applicability of RAC as a nutritional intervention in a general hospital.
- To determine the impact of RAC on capillary glucose levels in hypoglycemic inpatients.
Main Methods:
- Seventy-six conscious inpatients with capillary glucose levels between 50-70 mg/dL were included.
- Nutritional intervention involved administering 15-4 g of RAC.
- Capillary glucose levels were measured 15-20 minutes post-intervention.
Main Results:
- The nutritional intervention using RAC was effective in 97.6% of cases.
- RAC administration proved to be a non-invasive and applicable method.
- The intervention successfully restored capillary glucose levels in the studied population.
Conclusions:
- Rapid absorption carbohydrates are a potentially effective method for managing hypoglycemia in conscious inpatients.
- This nutritional strategy is applicable within a general hospital setting for patients on oral diets.
- RAC offers a practical approach to rapidly correct low blood glucose levels.
Related Concept Videos
01:15Hypoglycemia and Glucagon
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
01:14SBAR II: Application of SBAR
SBAR is an effective communication tool used by healthcare professionals to communicate patient information accurately. SBAR stands for Situation, Background, Assessment, and Recommendation. For a better understanding, an example is given below.
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
01:26Hypoglycemia
Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
01:06Oral Hypoglycemic Agents: Glinides
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively manages...
01:29Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood glucose levels...